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Abstract
b2 adrenergic receptor (b2AR) is a prototypical G-protein coupled receptor that stimulates the classic cAMP-protein kinase A
(PKA) signaling pathway. Recent studies indicate that the cAMP-PKA activities are spatiotemporally regulated in part due to
dynamic association of b2AR with phosphodiesterase 4D (PDE4D), a group of cAMP degradation enzymes. Here, we
demonstrate that in cardiomyocytes, palmitoylation of b2AR, the covalent acylation of cysteine residue 341, plays a critical
role in shaping subcellular cAMP-PKA activities in cardiomyocytes via regulating b2AR association with arrestin/PDE4D.
Replacing cysteine 341 on b2AR with alanine (C341A) leads to an impaired binding to b arrestin 2. Surprisingly, the C341A
mutant is able to internalize via an arrestin-independent pathway at saturated concentration of agonist stimulation; the
internalization becomes caveolae-dependent and requires dynamin GTPase. However, the impaired binding to b arrestin 2
also leads to an impaired recruitment of PDE4D to the C341A mutant. Thus, the mutant C341A b2AR is transported alone
from the plasma membrane to the endosome without recruiting PDE4D. This alteration leads to an enhanced cytoplasmic
cAMP signal for PKA activation under b2AR stimulation. Functionally, Mutation of the C341 residue or inhibition of
palmitoylation modification of b2AR enhances the receptor-induced PKA activities in the cytoplasm and increases in
myocyte contraction rate. Our data reveal a novel function of palmitoylation in shaping subcellular cAMP-PKA signaling in
cardiomyocytes via modulating the recruitment of b arrestin 2-PDE4D complexes to the agonist-stimulated b2AR.
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Introduction
b2AR plays important roles in cardiovascular and pulmonary
physiology [1,2]. Upon activation by catecholamines, b2AR
couples to stimulatory G protein, and activates adenylate cyclase
(AC) to produce cAMP. cAMP-dependent PKA phosphorylates
various proteins in cardiomyocytes, such as phospholamban, L-
type calcium channel, and troponins, resulting in increased heart
contraction force and rate [3].
Recently, PDE4D enzymes have been shown to control basal
levels of receptor phosphorylation by PKA via binding to b1AR
and b2AR and controlling local cAMP levels [4,5]. Specifically,
b1AR selectively binds to PDE4D8 [6] whereas b2AR binds
broadly to different PDE4D isoforms with strongest binding to
PDE4D9 at basal condition [7]. Moreover, agonist stimulation
leads to b2AR association with PDE4D5 and PDE4D8 specifically.
The recruitment of PDE4D isoforms plays a critical role in
controlling the spatiotemporal distribution of cAMP signal for
selective activation of PKA, and subsequent phosphorylation of
substrates for contractile responses [7].
Over the last decade, several types of post-translational
modifications on b2AR have been characterized. They are
implicated in receptor structure and signaling in mammalian cells
[8–13]. Among them, the role of b2AR phosphorylation by G
protein-coupled receptor kinases (GRKs) has been implicated in
receptor association with PDE4D enzymes. Upon agonist stimu-
lation, GRK-mediated b2AR phosphorylation leads to recruitment
of b arrestin 2, which serves as a scaffold protein to recruit
PDE4D5 and PDE4D8 [7]. The increased binding of PDE4D
isoforms to the activated receptor plays an essential role in
confining the cAMP-PKA activities in local environments and
dictating the specificity of receptor signaling. In comparison, the
role of b2AR palmitoylation and its effects on receptor signaling
and function in cardiomyocytes remain to be addressed.
Palmitoylation can be enhanced by isoproterenol stimulation
[14,15]. Losing b2AR palmitoylation leads to higher basal cAMP-
PKA activity. Early studies suggest that the palmitoylation of
b2AR reduces the receptor coupling to Gs proteins for activation
of adenylate cyclase and PKA phosphorylation of receptor in
Chinese hamster fibroblasts [16], the functional implication
remains unclear. In this context, we hypothesize that palmitoyla-
tion of b2AR affects the receptor signaling and function in
cardiomyocytes.
Thus, we set out to study how b2AR palmitoylation
influences receptor signaling pathway in cardiomyocytes. Spe-
cifically, we like to examine whether palmitoylation of b2AR
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affects agonist-induced receptor trafficking and receptor associ-
ation with other effectors like PDE4D isoforms in signaling
complex. Here, we validate that mutation of b2AR at
palmitoylation site C341A leads to less cAMP production on
the plasma membrane, consistent with the impaired Gs/AC
signaling as previously reported. More interestingly, we find that
the mutant receptor displays reduced association with PDE4Ds,
due to that it has reduced recruitment of b arrestin-2.
Surprisingly, the mutant receptor is able to internalize via an
arrestin-independent pathway. Therefore, the mutant receptor
internalizes alone without recruitment of PDE4Ds, leading to
altered spatial distribution of cAMP signal in cardiomyocytes,
low cAMP signal at the plasma membrane, and higher cAMP
signal in the cytoplasm. Functionally, inhibition of b2AR
palmitoylation or mutation of cysteine 341 leads to higher
PKA activity in the cytoplasm and increase in myocyte
contraction rate. In conclusion, our data indicate that
palmitoylation of b2AR is required for receptor association
with arrestin-PDE4Ds to shape subcellular cAMP level in
cardiomyocytes for contraction response.
Materials and Methods
Site Mutagenesis, Adenovirus Preparation and Cell
Culture
Mouse b2AR palmitoylation mutant (flag-b2AR-C341A) was
generated through site directed mutagenesis of cysteine 341 of
b2AR to alanine using pCDNA3.1-flag-b2AR as DNA template.
The mutant was sequenced and subcloned into adenovirus vector
pAdEasy-1 through recombination in bacteria BJ5831 for
adenovirus production in HEK293-QBI cells. Adenoviruses
expressing, N terminal PDE4D5-GFP, PDE4D8-GFP, PDE4D9-
GFP, and full length PDE4D5-RFP, PDE4D9-HA were created as
described previously [7]. Adenoviruses expressing adenylate
cyclase isoform VI (AC-VI) had been reported previously [17].
AKAP79-GFP was a gift from Dr. John Scott (University of
Washington). Dominant negative b arrestin 2-V54D and dynamin
K44E were described elsewhere [18]. HEK293 cells and mouse
embryonic fibroblasts [7] (MEFs, a gift from Dr. Robert
Lefkowitz, Duke University) lacking arrestin genes were cultured
in Dulbecco’s Modified Eagle’s Medium (DMEM) media before
transfected with plasmids expressing receptors and other con-
structs as indicated. Cells were stimulated before being processed
for immunofluorescence imaging.
Neonatal Cardiomyocytes Isolation, Total Intracellular
cAMP Measurement, and Myocyte Contraction Rate
Measurement
b1AR and b2AR double knockout (b1b2AR-KO) cardiomyo-
cytes were isolated by digestion of neonatal mouse heart tissue with
type II collagenase (Worthington, NJ) and cultured in DMEM
supplied with 10% fetal bovine serum. After overnight culture,
cells were washed with phosphate buffered saline (PBS) to remove
dead cells and then infected with adenoviruses expressing b2AR,
b2AR-C341A for 24 hours. For total intracellular cAMP
measurement, cells were treated in the presence or absence of
10 mM isoproterenol for 5 minutes or b2AR selective inverse
agonist ICI118551 (1 mM, Tocris, MN) for 30 minutes. Cells were
treated with 2-bromopalmitic acid (100 mM, Sigma, MO) 15
minutes to inhibit palmitoylation of b2AR, which has half-life of
9.8 minutes [15]. Total intracellular cAMP level was measured
using cAMP HTS immunoassay kit (Millipore, MA). Detailed
procedure for measuring myocyte contraction rate has been
described previously [19].
Radioligand Binding Assay
Neonatal cardiomyocytes overexpressing flag-b2AR or flag-
b2AR-C341A were washed once with cold PBS, harvested into
hypotonic lysis buffer (20 mM HEPES, pH 7.4, 1 mM EDTA,
1 mM PMSF, and 1 mM benzamidine). Cells were homogenized
for 20 strokes in a tight homogenizer followed by centrifugation for
10 minutes at 800 g to remove nuclei and unbroken cells. The
supernatant was further spun down for 20 minutes at 18,000 rpm
using a Beckman JC-M2 rotor to pellet the membrane, which was
resuspended by passage through 25-gauge needle in 16 binding
buffer (75 mM Tris-HCl, pH 7.4, 12.5 mM MgCl2, 1 mM
EDTA). After measuring protein concentration by BCA assay
(Pierce, IL), 20 mg of membrane protein containing b2AR was
incubated with 10 nM [3H] dihydroalprenolol (GE Healthcare,
Piscataway, NJ) for 1 hour at shaken speed of 230 rpm under
room temperature. 20 mg of membrane proteins from cardiac cells
without overexpression of b2AR were used as control. Membranes
were harvested and rinsed with 16 binding buffer. The
membrane-bound [3H] dihydroalprenolol was detected using a
Beckman LS 6500 liquid scintillation counter (Beckman Coulter,
Fullerton, CA).
Receptor Internalization and Recycling
b1b2AR-KO cardiomyocytes were infected with adenoviruses
expressing flag-b2AR, flag-b2AR-C341A for 24 hours. Cells were
serum starved for 30 minutes, and in some cells, treated with
2 mg/ml filipin for 30 minutes, and then stimulated with 10 mM
isoproterenol for different time as indicated to examine receptor
internalization. For determination of receptor recycling, cells were
stimulated with 10 mM isoproterenol for 10 minutes followed by
drug removal to allow receptor recycling for 30 minutes and 60
minutes. Cells were fixed with 4% paraformaldehyde and
permeabilized with 0.2% Nonidet P-40 and stained with anti-flag
antibody (mouse IgG2b, Sigma, MO), followed by Alex-594
conjugated secondary antibody against mouse IgG2b (Invitrogen,
CA). Images were captured with a CCD camera on a Zeiss
microscope with MetaMorph software. Quantification of receptor
internalization and recycling using FLISA method had been
described in previous studies [20].
Purification of Caveolin-rich Membrane Fractions
Neonatal cardiomyocytes expressing flag-b2AR or flag-b2AR-
C341A were collected into cold PBS and harvested by
centrifugation. Cells were resuspended in 2 ml 0.5 M Na2CO3
(pH,11). After gentle vortexing, 1.75 ml sample was mixed
with 1.75 ml 80% sucrose buffer (25 mM MES, pH 6.5,
0.15 M NaCl, 80% sucrose) and loaded onto the bottom of
ultracentrifuge tube. A two-step gradient was loaded onto the
top of the sample with 3.5 ml 35% sucrose buffer (25 mM
MES, 0.15 M NaCl, 250 mM Na2CO3, 35% sucrose) and 4 ml
5% sucrose buffer (25 mM MES, 0.15 M NaCl,
250 mM Na2CO3, 5% sucrose). Sample was spun down in a
Beckman SW41 rotor for 18 hours at 38,000 rpm. 1 ml fraction
was collected from top to bottom and mixed with 10%
trichloroacetic acid for protein precipitation for 4 hours on
ice. The protein pellet was dissolved in 16 SDS-sample buffer.
Proteins after precipitation was collected by centrifugation for
30 minutes at 13,200 rpm, washed twice with 100% cold
acetone and dissolved in 16 SDS-sample buffer. Proteins were
separated by 12% SDS-PAGE for detection of caveolin-3 (BD,
NJ), flag-b2AR or flag-b2AR-C341A by anti-flag antibody
(Sigma, MO), and Src (Cell Signaling, MA).
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Co-immunoprecipitation and Western Blot
Cells overexpressing flag-b2AR, flag-b2AR-C341A, or together
with individual PDE4D isoforms or GFP-b arrestin 2 were
stimulated with 10 mM isoproterenol and harvested into lysis
buffer (20 mM HEPES, pH 7.4, 0.6% Nonidet P-40,
150 mM NaCl, 2 mM EDTA, 10% glycerol, 0.03% n-Dodecyl-
b-D-maltoside (Enzo Life Sciences, PA), 1 mM PMSF, 1 mM
benzamidine, 1 mM NaF, 1 mM Na3VO4). Protein samples were
lysed for 40 minutes at 4uC before centrifugation for 10 minutes at
16,000 g to collect supernatant. Receptors were immunoprecip-
itated by anti-flag M2 affinity resin (Sigma, MO) for 2 hours at
4uC and eluted into 2x SDS-sample buffer for SDS-PAGE. After
transfer onto nitrocellulose membrane, proteins were blotted with
5% non-fat milk in 1x TBST and subsequently blotted with the
following antibodies: endogenous PDE4 (Abcam, CA), GFP
(Clontech, CA), anti-flag (Sigma, MO), caveolin-3 (BD, NJ),
RFP (Thermofisher, IL), HA (Covance, CA). The optical density
of the bands was analyzed with ImageJ (National Institute of
Health, MD, USA).
Receptor Phosphorylation
Cardiomyocytes expressing flag-b2AR or flag-b2AR-C341A
were serum starved for 30 minutes before stimulation with
10 mM isoproterenol for different time as indicated. Proteins were
harvested and subjected to SDS-PAGE for Western blot with
antibodies against total b2AR, phospho-b2AR by PKA on serines
261/262 [21], and phospho-b2AR by GRK on serines 355/356
(SCBT, CA).
Fluorescence Resonance Energy Transfer (FRET)
The detailed procedures to measure real time cAMP/PKA
activity in living cardiomyocytes using the FRET technique
described in previous study [21]. In brief, b1b2AR-KO neonatal
cardiomyocytes were infected with adenoviruses expressing b2AR
or b2AR-C341A, along with cytoplasmic cAMP FRET biosensor
ICUE3, plasma membrane targeted cAMP FRET biosensor PM-
ICUE3, or PKA FRET biosensor AKAR2.2 [22,23]. After
overnight expression, cells were washed twice with PBS and
challenged by 10 nM or 10 mM isoproterenol as indicated. Cells
were treated with 2-bromopalmitic acid (100 mM, Sigma, MO) 15
minutes to inhibit palmitoylation of b2AR. Rolipram was added at
final concentration of 10 mM to inhibit all PDE4 activities in the
cells. Images were captured every 20 seconds and the ratio
between emission of YFP and that of CFP was plotted as an
indicator of dynamic activity change that was automatically
analyzed by Metafluor software. Basal line substraction was
performed using Origin software. Data analysis was performed by
GraphPad Prism software.
Statistical Analysis
All statistical analyses were performed using GraphPad Prism
software. p,0.05 was considered statistically significant.
Results
Disruption of Palmitoylation of b2AR Enhances Agonist-
induced cAMP-PKA Activation in the Cytoplasm and
Myocyte Contraction Response
We used two complimentary strategies to examine the
functional implication of palmitoylation of b2AR in cardiomyo-
cytes. First, a point mutation was introduced on human b2AR to
generate b2AR-C341A, in which the cysteine residue was replaced
by alanine. Both mutant and wild type b2AR were expressed in
cardiomyocytes lacking endogenous b1 and b2ARs (DKO).
Activation of the mutant b2AR-C341A by 10 mM of isoproterenol
induced a higher increase in myocyte contraction rate than wild
type receptor (Figure 1A) even though both receptors displayed
equivalent expression measured by [3H] dihydroalprenolol ligand
binding and by Western blot (Figure 1B). Second, we applied 2-
bromopalmitic acid to inhibit receptor palmitoylation [24], which
selectively enhanced the contraction rate increase induced by wild
type receptor, but not those by C341A mutant (Figure 1A). To
validate the observation of functional contraction response, we
examined the cAMP activities in the cytoplasm, which is relevant
to PKA activation at the intracellular compartments such as
sarcoplasmic reticulum, calcium storage for cellular calcium
signaling and contractile response. We applied the cytoplasmic
cAMP FRET sensor ICUE3 to measure the cAMP dynamics.
Activation of b2AR-C341A induced higher cAMP FRET
responses than WT receptor in the cytoplasm (Figure 1C and
1E). Inhibition of receptor palmitoylation with 2-bromopalmitic
acid selectively enhanced the cAMP FRET signals in the
cytoplasm induced by WT b2AR but not by b2AR-C341A, and
abolished the difference between the two receptors (Figure 1D and
1E). These data are consistent with the cAMP accumulation
measured by cAMP immunoassay in cell lysates (Figure S1). In
agreement with cAMP data, activation of b2AR-C341A by
isoproterenol induced higher increases in PKA activities measured
by FRET biosensor AKAR2.2 in the cytoplasm than WT b2AR
(Figure 1F). 2-bromopalmitic acid treatment selectively enhanced
increases in PKA activities induced by stimulation of WT b2AR
(Figure 1E).
Disruption of Palmitoylation of b2AR Alters Spatio-
temporal Distribution of Agonist-induced cAMP in
Cardiomyocytes
Previous study on b2AR palmitoylation in Chinese hamster
fibroblasts suggests that mutation of the palmitoylation residue
reduces b2AR/Gs coupling to activate adenylate cyclases for
cAMP production on the isolated plasma membrane [14]. Here,
we observed that intracellular cAMP and PKA levels in
myocytes expressing b2AR-C341A were higher than those with
WT receptor, leading higher contraction rate response under
agonist stimulation (Figure 1). This observed difference suggests
a potential alteration of subcellular distribution of cAMP signal
between the plasma membrane and the cytoplasm under
stimulation of the mutant b2AR-C341A. Besides Gs/AC-
dependent cAMP production, the cAMP dynamics can also
be modulated by b2AR-associated PDE4D for cAMP degrada-
tion [7,17]. We envisioned that the mutant receptor also caused
alteration in the membrane trafficking of b2AR and its
associated PDE4D. To test this hypothesis, we first tried to
validate the coupling efficiency between the mutant receptor
and Gs/AC axis. We applied the plasma membrane-localized
FRET biosensor to directly measure cAMP in the local domain
produced by receptor activation in living myocytes. By using a
low concentration of 10 nM isoproterenol, at which the ligand-
bound receptor only activates Gs protein without undergoing
internalization and Gi coupling [21], we selectively analyzed
receptor/Gs coupling of the mutant b2AR-C341A. At minimal
10 nM isoproterenol, b2AR-C341A induced a lower cAMP
FRET response at the plasma membrane than WT receptor
(Figure 2A). Inhibition of PDE4 with rolipram enhanced the
FRET responses induced by both receptors, but the difference
between increases induced by two receptors still remained
(Figure 2A). These data are consistent with previous publica-
tions showing that the mutant b2AR-C341A has impaired
Palmitoylation Regulates b2AR Signaling in Myocyte
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coupling to Gs protein for cAMP production [14]. At the same
concentration of isoproterenol stimulation, b2AR-C341A in-
duced a lower cAMP FRET response in the cytoplasm than
WT receptor (Fig. 2C). However, at 10 mM isoproterenol
stimulation, while the cAMP signals at the plasma membrane
induced by C341A was lower than wild type receptor
(Figure 2B), the cAMP signal in the cytoplasm induced by
C341A was higher than wild type receptor (Figure 2D). We
hypothesize that the trafficking of activated receptor and its
associated PDE4D shape the subcellular cAMP signals at high
concentration of isoproterenol stimulation. In supporting this
notion, inhibition of PDE4 enhanced cAMP signals and
normalized the difference between the two receptors in both
measurements of cAMP in the cytoplasm by FRET assay and
cAMP accumulation by immunoassay (Figure S2).
Disruption of Palmitoylation of b2AR Reduces Receptor
Association with PDE4D Isoforms at Both Resting and
Stimulating Conditions
We then examined the association of PDE4D with mutant
b2AR-C341A. b2AR-C341A displayed a reduced association with
PDE4 in both HEK293 cells and neonatal cardiomyocytes
(Figure 3A and 3C). In contrast, mutant b2AR-C341A did not
change the receptor association with adenylate cyclase VI, one of
the major adenylate cyclase isoforms expressed in cardiomyocytes
as well as the receptor complex scaffold protein AKAP79
(Figure 3B and 3D). These data indicate that the mutation on
b2AR palmitoylation site at C341 selectively reduces receptor
association with PDE4 without globally disrupting association with
AKAP and adenylate cyclase.
Figure 1. Stimulation of palmitoylation mutant b2AR leads to higher and sustained intracellular cAMP-PKA activities and higher
increases in cardiomyocyte contraction rate. b1b2AR-KO cardiomyocytes expressing b2ARs via adenovirus infection were stimulated with
isoproterenol (10 mM). The spontaneous contraction rate was recorded before and after isoproterenol stimulation. A) Quantification of isoproterenol-
induced cardiomyocyte contraction rate increases over the baseline levels was plotted in the absence or presence of treatment with 2-bromopalmitic
acid. B) 20 mg membrane protein containing b2ARs was determined by radioligand [
3H] DHA binding to measure expression levels of b2AR and b2AR-
C341A. The expressed receptors were also detected by Western blot using anti-flag antibody. b1b2AR-KO cardiomyocytes expressing b2ARs together
with cytoplasmic cAMP FRET biosensor ICUE3 (C-E) or PKA activity biosensor AKAR 2.2 (F). (C) and (D) Cells were stimulated with isoproterenol
(10 mM) to record the changes of FRET ratio. 2-Bro, 2-bromopalmitic acid (100 mM) was added 15 minutes before Iso stimulation; Quantification of
isoproterenol-induced maximal increases in cAMP FRET ratio (E) and PKA FRET ratio (F) was plotted. In each panel, bar graphs were average from the
maximal increases in the indicated number of cells (FRET assay) or dishes (beating assay) from at least three independent experiments. *, p,0.05 in
comparison to WT control stimulated with Iso alone by one-way ANOVA;#, p,0.05 between WT and C341A stimulated with Iso by two-way ANOVA.
doi:10.1371/journal.pone.0042658.g001
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Among four PDE4 subfamilies, PDE4D subfamily contribute to
60% of total PDE4 enzymatic activities and regulate bAR
signaling in cardiomyocytes [4]. Nine PDE4D isoforms have been
identified which share identical catalytic domains and unique N
terminal for distinct subcellular localization [25]. We have
previously reported differential association of PDE4D enzymes
with b2AR in cardiomyocytes at resting and stimulating conditions
to modulate receptor-induced cAMP signal [7]. Only PDE4D9
displayed less association with b2AR-C341A at basal condition,
consistent with the prominent role of this enzyme in controlling
local cAMP and basal PKA phosphorylation of protein in receptor
complex at resting state (Figure 3E and [7]). Consistently,
overexpression dominant negative PDE4D9 or inhibition of
PDE4 selectively enhanced cAMP levels in cells expressing wild
type receptor, but not in those expressing b2AR-C341A at resting
state (Figure S3).
Arrestin plays a role in PDE4D association with b2AR in resting
state [7]. We then investigated whether palmitoylation regulates
the association among PDE4D isoforms, arrestins, and b2AR.
Consistent with the data in cardiomyocytes, b2AR-C341A
displayed less association with PDE4D9 than WT receptor at
resting state in WT MEFs, but not in MEFs lacking arrestin
proteins (Figure 3F), indicating a necessary role of arrestin in
mediating palmitoylation-dependent binding of b2AR to
PDE4D9. Upon agonist stimulation, PDE4D5 and PDE4D8,
but not PDE4D9 are recruited to the activated receptor via
scaffold protein b arrestin 2 (Figure 4A–4C and [7]). However, the
recruitment of both PDE4D5 and 4D8 to b2AR-C341A was
significantly reduced compared with that to WT b2AR (Figure 4A–
4B), indicating the necessary role of palmitoylation for the b
arrestin 2-dependent association of PDE4D with activated b2AR.
Moreover, loss of b arrestin 2 abolished the agonist-induced
recruitment of PDE4D5 to WT b2AR in MEFs (Figure 4D),
further validating the critical role of b arrestin 2 in scaffolding
PDE4Ds for regulating b2AR signaling.
Disruption of Palmitoylation of b2AR Reduces
Recruitment of Arrestin to the Phosphorylated Receptor
Under Agonist Stimulation
The agonist-induced binding of PDE4D to activated b2AR is
dependent on the recruitment of arrestin. We suspected that the
agonist-induced recruitment of b arrestin 2 to bAR is reduced by
mutation of the palmitoylation site. In cardiomyocytes, b arrestin 2
had abundant expression whereas b arrestin 1 expression was low
(Figure S4). b2AR-C341A displayed a reduced recruitment of b
arrestin 2 upon agonist stimulation when compared to wild type
Figure 2. Mutation of palmitoylation reduces b2AR/G protein-dependent cAMP production in cardiomyocytes. b1b2AR-KO
cardiomyocytes were infected with adenoviruses expressing b2ARs together with the plasma membrane-targeted cAMP FRET biosensor PM-ICUE3
(A and B) or cytoplasmic cAMP FRET biosensor ICUE3 (C and D). Cells were stimulated with 10 nM of isoproterenol (A and C) or 10 mM of
isoproterenol (B and D). The maximal increases in FRET ratio were plotted. Rol, rolipram, was added together with Iso at 10 mM. Bar graphs were
average from the maximal increases in time courses. *, p,0.05 by t-test in comparison to WT b2AR.
doi:10.1371/journal.pone.0042658.g002
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Figure 3. Palmitoylation is required for b2AR association with phosphodiesterase 4. Cells expressing flag-b2ARs alone (A and C) or
together with adenylate cyclase VI (B), AKAP-GFP (D), GFP-PDE4D (E), or PDE4D9-HA (F) were lysed for immunoprecipitation with anti-flag M2 beads.
The bound proteins were detected in Western blot by anti-flag, anti-GFP, anti-PDE4, anti-adenylate cyclase VI, anti-GFP, and anti-HA antibodies.
Western blot was quantified and normalized against the IP protein. Bar graphs were average from 3–5 different experiments. *, p,0.05 by t-test
between WT and C341A.
doi:10.1371/journal.pone.0042658.g003
Figure 4. Palmitoylation of b2AR is required for agonist-dependent recruitment of arrestin-PDE4D complexes to the receptor.
b1b2AR-KO cardiomyocytes expressing flag-b2ARs together with GFP-PDE4D5 (A), GFP-PDE4D8 (B), or GFP-PDE4D9 (C) were serum-starved for 30
minutes before stimulation with 10 mM of isoproterenol as indicated. Cell lysates were incubated with anti-flag M2 beads for co-immunoprecipitation
of b2ARs and PDE4D proteins. The bound proteins were detected in Western blot by anti-flag and anti-GFP antibodies as indicated. D) Flag-b2ARs and
PDE4D5-RFP were expressed in wild type and arrestins double knockout (KO) MEF cells. Co-IP was done like those in panel (A–C). The bound proteins
were detected in Western blot by anti-flag and anti-RFP antibodies as indicated. Western blot was quantified and normalized against the IP protein.
Bar graphs were average from 3–5 different experiments. *, p,0.05 by one-way ANOVA in comparison to WT b2AR without stimulation.
#, p,0.05 by
t-test to WT control.
doi:10.1371/journal.pone.0042658.g004
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receptor (Figure 5A). The recruitment of arrestin is dependent on
receptor phosphorylation by GRK. Surprisingly, b2AR-C341A
displayed normal phosphorylation by GRKs in comparison to the
wild type b2AR upon isoproterenol stimulation. PKA phosphor-
ylation of b2AR-C341A was higher at resting condition than wild
type receptor; and the agonist-induced PKA phosphorylation was
more sustained compared to that of WT b2AR (Figure 5B and
Figure S5). This is consistent with previous report on higher PKA
phosphorylation of mutant C341G receptor expressed in fibro-
blasts [16,26]. Phosphorylation of b2AR plays a significant role in
receptor desensitization through b arrestin-dependent pathway
[8]. The observation of normal GRK phosphorylation but
reduced recruitment of b arrestin 2 to b2AR-C341A (Figure 5A
and 5B) prompted us to examine arrestin-dependent receptor
internalization after agonist stimulation. To our surprise, b2AR-
C341A displayed normal time-dependent internalization similar to
that of WT receptor (Figure 6A and 6B). Moreover, both WT and
C341A mutant displayed sufficient recycling upon isoproterenol
removal (Figure 6A and 6C). Consequently, the cAMP signal
induced by either wild type or mutant b2AR-C341A were sensitive
to inhibition of Gi (Figure S6), indicating that both receptors are
capable to couple to Gi after agonist-induced receptor transloca-
tion [27,28]. As a control, a b2AR lacking critical GRK sites for
arrestin binding and internalization showed impaired internaliza-
tion (Figure 6A and 6D), consistent with early studies showing that
b2AR internalization is dictated by GRK phosphorylation in
cardiomyocytes [21].
Disruption of Palmitoylation of b2AR Alters Agonist-
induced Receptor Internalization Pathway
We then further explored the mechanism underlying the
agonist-induced internalization of b2AR-C341A with MEF cells
lacking individual arrestin genes. Deletion of b arrestin 2, but not
b arrestin 1 gene selectively blocked isoproterenol-induced
internalization of WT receptor, but did not affect the internali-
zation of b2AR-C341A (Figure 7). These data indicate that b2AR-
C341A undergoes internalization via an arrestin-independent
pathway. GPCR can undergo internalization via both arrestin-
and caveolae-dependent pathways although both pathways are
dependent on the dynamin GTPase [29,30]. b2AR has been
shown to be localized in caveolae/lipid rafts for proper signaling
and function [31], we examined whether palmitoylation plays a
role in b2AR localization in caveolae, thus modulating the
receptor trafficking properties upon agonist stimulation. Both
b2AR and b2AR-C341A were enriched in caveolae-rich mem-
brane fraction, which was further supported by co-immunopre-
cipitation between receptor and caveolin-3 (Figure 8A and 8B).
While b2AR and b2AR-C341A displayed normal internalization
upon isoproterenol stimulation (Figure 8C), the receptor internal-
ization was completely blocked by overexpression of dominant
negative dynamin K44E in HEK293 cells (Figure 8D). Mean-
while, pretreatment with filipin, a drug that disrupts lipid rafts/
caveolae [32], inhibited isoproterenol-induced internalization of
b2AR-C341A (Figure 8F). In comparison, overexpression of
dominant negative b arrestin 2 V54D only partially inhibited
isoproterenol-induced internalization of b2AR-C341A (Figure 8E).
Together, these data suggest that b2AR-C341A utilizes additional
caveolin-dependent pathway for internalization that is dependent
on dynamin GTPase.
Discussion
Palmitoylation is a common feature shared by many G-protein
coupled receptors. In the present study, we reveal a couple of new
functional properties of palmitoylation of b2AR in function and
signaling. First, palmitoylation of b2AR is required for receptor
signaling complex formation. Disruption of palmitoylation of
Figure 5. Palmitoylation of cysteine 341 of b2AR is required for agonist-induced recruitment of b arrestin 2, but not receptor
phosphorylation by PKA and GRK. b1b2AR-KO cardiomyocytes expressing flag-b2ARs and b arrestin 2-GFP were serum-starved for 30 minutes
before stimulation with 10 mM of isoproterenol as indicated. (A) Cell lysates were incubated with anti-flag M2 beads to immunoprecipitate flag-b2ARs.
The bound proteins were detected in Western blot by anti-flag and anti-GFP antibodies. *, p,0.05 by t-test in comparison to the control without
stimulation. (B) Cell lysates were used to detect receptor phosphorylation by PKA on serine 261/262 or GRKs on serine 355/356 by anti-phospho-
serine 261/262 and anti-phospho-serine 355/356 specific antibodies as indicated. Western blots were quantified and normalized against the total
b2AR expression. Bar graphs were average from 3–5 different experiments.
#, p,0.05 by two-way ANOVA in comparison to WT control.
doi:10.1371/journal.pone.0042658.g005
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b2AR selectively abolishes the receptor interaction with b arrestin
2 and PDE4D enzymes for cAMP degradation without affecting
the receptor association with AKAP and adenylate cyclase.
Second, palmitoylation of b2AR modulate the receptor endocytic
pathways under agonist stimulation. Mutation on palmitoylation
site of b2AR shifts the receptor internalization from an arrestin-
dependent pathway to a caveolae-dependent pathway. Thus, the
mutant b2AR is able to undergo internalization without recruiting
arrestin and PDE4 enzymes. This leads to altered redistribution of
PDE4 enzymes from the plasma membrane to intracellular
endosomal compartments, which changes the cAMP dynamics
in these subcellular compartments under agonist stimulation of
b2AR. As a result, activation of the mutant b2AR leads to higher
intracellular cAMP level in cardiomyocytes to promote stronger
PKA activity and myocyte contraction response.
Recent studies provide accumulating evidence on elaborated
complex formation of GPCRs with their signaling partners. These
data demonstrate a tightly regulated and dynamic equilibrium
between the receptor complex with stimulatory adenylate cyclases
for second messenger cAMP production and the receptor complex
with inhibitory phosphodiesterases for cAMP hydrolysis. b2AR is
known to bind to AKAP79 and AKAP250 [33], and both
Figure 6. Mutation of palmitoylation site does not inhibit agonist-induced b2AR trafficking. A) b1b2AR-KO cardiomyocytes expressing
wild type or mutant flag-b2ARs were stimulated with 10 mM isoproterenol to examine receptor internalization or followed by agonist removal to
examine receptor recycling. Receptors were stained by anti-flag antibody M1 and Alex 488-conjugated goat-anti-mouse secondary antibody. Maximal
internalization of different flag-b2ARs in b1b2AR-KO cardiomyocytes at 30 minute of stimulation was plotted in bar graph. Receptors remaining on the
cell surface after internalization (B and D) or recycling (C) were quantified using Alex 488-conjugated flag antibody labeling. Quantitative
measurements of cell surface receptor were average from at least three different experiments. *, p,0.05 by t-test in comparison to WT b2AR.
doi:10.1371/journal.pone.0042658.g006
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AKAP79 and mAKAP is shown to scaffold adenylate cyclases to
facilitate signaling transduction efficiency and specificity [34]. On
the contrary, b2AR binds to PDE4 enzymes in an arrestin-
dependent manner [7], which shapes the spatiotemporal distribu-
tion of intracellular cAMP. In one recent example, relaxin
receptor is able to form a stable complex with both AKAP79-
anchored AC and arrestin-associated PDE4. This complex allows
maintaining a tonic cAMP signal induced by the receptor [35]. We
find that mutation of palmitoylation site on b2AR displays a
reduced binding to PDE4D without affecting the binding to
AKAP79 and AC. This reduced binding of PDE4D9 is due to that
the mutant b2AR displays a reduced association of b arrestin 2
(Figure 3), similar to the effect of palmitoylation on the recruitment
of arrestin to activated vasopressin receptor [36]. Under agonist
stimulation, the mutant b2AR-C341A also displays reduced
association with PDE4D5 and PDE4D8 (Figure 4), which is again
due to a reduced recruitment of b arrestin 2 to activated receptor
(Figure 5). Therefore, palmitoylation is required for b2AR binding
to b arrestin 2, which is necessary to connect PDE4D enzymes to
the receptor.
Despite the inability of the mutant b2AR-C341A to recruit b
arrestin 2, the receptor is able to undergo agonist-induced
internalization via a caveolae-dependent pathway. This is
consistent with report that b1AR is able to internalize via both
clathrin and caveolae-dependent pathways in HEK293 cells,
which is dependent on receptor phosphorylation by GRK2 and
PKA respectively [37]. Accordingly, the mutant b2AR-C341A
displays normal GRK phosphorylation but an increased and
prolonged PKA phosphorylation under agonist stimulation. The
increased PKA phosphorylation may promote PKA-dependent
Figure 7. Mutation of palmitoylation site allows agonist-induced b2AR internalization via an arrestin-independent pathway. MEFs
(WT, b arrestin 1-KO or b arrestin 2-KO) expressing flag-b2ARs or flag-b2AR-C341A were serum starved for 30 minutes before stimulation with
isoproterenol 10 mM for 30 minutes to examine receptor internalization. A-C), cells were fixed, and receptors were stained by anti-flag antibody M1
and Alex 488-conjugated goat-anti-mouse secondary antibody. D), Cells surface receptor level after agonist stimulation was measured by FLISA
method.
doi:10.1371/journal.pone.0042658.g007
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Figure 8. Mutation of palmitoylation site promotes caveolin-dependent b2AR internalization upon agonist stimulation. A) Membrane
fractionations of b1b2AR-KO cardiomyocytes expressing b2AR or b2AR-C341A were blotted with caveolin-3, Src, and flag antibodies. P is the pellet
fraction after centrifugation. B) Cell lysates were incubated with M2 beads for immunoprecipitation of flag-b2ARs to detect endogenous caveolin-3
association. (C–F) HEK293 cells expressing b2AR or together with other proteins were stimulated with 10 mM isoproterenol for 30 minutes to examine
receptor internalization. C) Cells expressing flag-b2AR alone, D) cells expressing flag-b2ARs together dominant negative dynamin K44E, F) cell
expressing flag-b2ARs were treated with 2 mg/ml filipin for 30 minutes, and E) cells expressing flag-b2AR-C341A together with b arrestin 2 (b arr2) or
dominant negative b arrestin 2-V54D (b arr2-V54D), before stimulation with isoproterenol 10 mM for 30 minutes to examine receptor internalization.
Cells were fixed, and receptors were stained by anti-flag antibody M1 and Alex 594-conjugated goat-anti-mouse secondary antibody.
doi:10.1371/journal.pone.0042658.g008
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internalization of the mutant receptor via the caveolae-
dependent pathway. Meanwhile, mutation of GRK phosphor-
ylation sites reduces agonist-induced internalization, in agree-
ment with the critical role of GRK phosphorylation for arrestin-
mediated b2AR internalization and desensitization [8]. Togeth-
er, both GRK phosphorylation and palmitoylation are necessary
for recruitment of arrestin for internalization of the activated
b2AR; mutation of palmitoylation promotes PKA phosphoryla-
tion, and PKA-dependent internalization via caveolae-mediated
pathway.
The structural properties involved in palmitoylation for
selective binding of receptor to arrestin, but not to AKAPs
remains to be determined. The mutant b2AR-C341 also
displays normal association with caveolin, indicating that the
modification is not required for caveolae-targeting. This
observation is similar to those palmitoylation sites reported on
caveolin-1, but different from palmitoylation-dependent target-
ing to lipid rafts by other proteins including G protein signaling
proteins (RGS) [38], G proteins [39], SNAP proteins [40], and
Ras proteins [41]. While the mutant b2AR-C341 undergoes
internalization via the caveolae-dependent pathway, dominant
negative dynamin K44E completely blocks the internalization
(Figure 8F and 8D). The observations are consistent with other
studies showing that GPCRs can undergo different internaliza-
tion pathways including both arrestin-dependent and caveolin-
dependent endocytosis [29,30], and both internalization path-
ways require the activity of dynamin GTPase.
The b2AR-induced intracellular cAMP/PKA signaling is
shaped by dynamic equilibrium between Gs/AC-mediated cAMP
production and PDE-mediated cAMP hydrolysis. The mutant
b2AR-C341A displays an impaired coupling to Gs protein for
cAMP production. Here, the reduced association of PDE4D with
mutant b2AR-C341A has profound effects on subcellular dynam-
ics of cAMP in cardiac myocytes. The mutant b2AR-C341A
undergoes internalization without recruiting the PDE4D, which
alters the subcellular distribution of PDE4D and contributes to a
higher and more sustained intracellular cAMP accumulation
under agonist stimulation. Consequently, the mutant b2AR-
C341A induces higher PKA activity and contraction response in
cardiomyocytes. Together, we have shown that palmitoylation of
b2AR modulates receptor signaling in cardiomyocytes via regu-
lating the receptor-associated complexes. These complexes poten-
tially limit the cAMP signaling in local environments, which not
only contributes to receptor signaling specificity but also protects
cells from overstimulation.
Supporting Information
Figure S1 b1b2AR-KO cardiomyocytes were infected
with adenoviruses expressing flag-b2AR or flag-b2AR-
C341A for 24 hours. A) Total cAMP levels after 5 minutes
Iso(10 mM) stimulation were measured using cAMP HTS
immunoassay kit. 2-bromopalmitic acid (100 mM) was added 15
minutes before cells were lysed for cAMP assay. Bar graphs
represent average from at least three experiments. *, p,0.05 in
comparison to WT control stimulated with Iso alone by one-way
ANOVA.
(EPS)
Figure S2 (A) b1b2AR-KO cardiomyocytes expressing b2ARs
along with cAMP FRET biosensor ICUE3 were stimulated with
10 mM isoproterenol. Rolipram (Rol, 10 mM isoproterenol as
indicated. The changes in ICUE3 FRET ratio were recorded, and
the maximal changes in FRET ratio were plotted. (B) b1b2AR-KO
cardiomyocytes expressing b2ARs were stimulated with 10 mM
isoproterenol for 5 minutes. Rolipram was added together with
isoproterenol as indicated. Cells were lysed and the cAMP
accumulations were determined with using cAMP HTS immuno-
assay kit. Bar graphs represent average from at least three
experiments. *, p,0.05 in comparison to WT control stimulated
with Iso alone by one-way ANOVA.
(EPS)
Figure S3 b1b2AR-KO cardiomyocytes expressing b2ARs
along with dominant negative PDE4D9 as indicated were
stimulated with 10 mM isoproterenol for 5 minutes. Cells
were lysed and the cAMP accumulations were determined with
using cAMP HTS immunoassay kit. Bar graphs represent average
from at least three experiments. *, p,0.05 in comparison to WT
control stimulated with Iso alone by one-way ANOVA.
(EPS)
Figure S4 Detection of endogenous b arrestin 1 and b
arrestin 2 in cardiomyocytes by b arrestin 1 and b
arrestin 2 antibodies. Lane 1, cell lysate from HEK293 cells
transiently expressing b arrestin 1-GFP; Lane 2, cell lysate from
HEK293 cells transiently expressing b arrestin 2-GFP; Lane 3, cell
lysate from neonatal cardiomyocytes.
(EPS)
Figure S5 b1b2AR-KO cardiomyocytes expressing b2ARs
were lysed for detection of PKA phosphorylation of
serine 261/262 by anti-phospho-serine 261/262 specific
antibody. Western blots were quantified and normalized against
the total b2AR expression. *, p,0.05 in comparison to WT
control stimulated with Iso alone by t-test.
(EPS)
Figure S6 b1b2AR-KO cardiomyocytes transiently expressing
b2AR (A) or b2AR-C341A (B) along with cAMP FRET biosensor
ICUE3 were pretreated with PTX (300 ng/ml) for 2 hours before
stimulation with 10 mM isoproterenol. The changes in cAMP
FRET over baseline level were recorded. The maximal changes
over the basal levels were plotted. *, p,0.05 in comparison to WT
control stimulated with Iso alone by one-way ANOVA.
(EPS)
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